Barclays Raises Energy Transfer Price Target Suggests Stock May Be Undervalued ICICI Securities Highlights Bharti Airtel HAL Among Seven LargeCap Stocks With Upside Potential of up to 28 Q4 Results 2026 RVNL Suzlon ONGC IRCTC GMR Airports IndiGo Among Firms Set to Report Next Week US Productivity Growth Cools in Q4 as Labor Costs Rise at Faster Pace Moroccos Tourism Push in Western Sahara Economic Opportunity or Political Leverage Deutsche Bank Aktiengesellschaft DB Shows Resilient Core Business Despite Market Volatility New Found Gold Corp NFGC Q1 2026 Earnings EPS Miss Highlights Exploration Stage Challenges Citi Q1 2026 Earnings EPS Surpasses Estimates by 133 Amid Improved Operational Efficiency MarineMax Inc HZO Q1 2026 Earnings EPS Falls Short of Expectations Amid Challenging Environment Cathay General Bancorp CATY Q1 2026 Earnings Strong EPS Surprise of 2275 Drives Profit Beat Despite Stock Dip AENT Q1 2026 Earnings Massive EPS Surprise Drives Stock Higher GIL Q1 2026 Earnings Strong EPS Beat Amid Modest Market Response CPI Aerostructures CVU Edges Higher Testing Key Resistance Near 524 Corcept Therapeutics CORT Rallies Sharply Pushing Toward Resistance at 69 Gladstone Investment 4875 Notes GAINZ Stability Amidst Flat Trading Yield Opportunity in Focus Compass Therapeutics CMPX Breaks Out Biotech Stock Rallies 6 Toward Resistance Akamai Technologies AKAM Edges Higher as Bulls Test Resistance Near 157 Natural Gas Futures Decline as Warmer Weather Forecasts Reduce Heating Demand TDG Q1 2026 Earnings EPS Surpasses Estimates on Robust Aerospace Demand CION Investment Corporation CION Edges Higher Testing Key Technical Levels Amid Volume Analysis Haoxi Health Technology Limited HAO Plunges 16 Key Levels to Watch Lixte Biotechnology Holdings LIXT Faces Selling Pressure as Shares Dip 34 Tower Semiconductor TSEM Edges Higher as Support Holds Near 265 Level Caesars Entertainment CZR Advances Slightly Nears Key Resistance at 3053 V2X Inc VVX Gains 265 Approaches Key Resistance at 7973 Globa Terra Acquisition Corporation Rights GTERR Surges 22 Rights Trading Above Support Polaryx Therapeutics PLYX Slips 271 as Stock Tests Key Support Near 238